Your browser doesn't support javascript.
loading
Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies.
Blauvelt, A; Paul, C; van de Kerkhof, P; Warren, R B; Gottlieb, A B; Langley, R G; Brock, F; Arendt, C; Boehnlein, M; Lebwohl, M; Reich, K.
Afiliación
  • Blauvelt A; Oregon Medical Research Center, Portland, OR, USA.
  • Paul C; Paul Sabatier University, Toulouse, France.
  • van de Kerkhof P; Radboud University, Nijmegen, the Netherlands.
  • Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, The University of Manchester, Manchester, UK.
  • Gottlieb AB; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Langley RG; Dalhousie University, Halifax, NS, Canada.
  • Brock F; UCB Pharma, Slough, UK.
  • Arendt C; UCB Pharma, Brussels, Belgium.
  • Boehnlein M; UCB Pharma, Monheim, Germany.
  • Lebwohl M; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Reich K; Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Br J Dermatol ; 184(4): 640-651, 2021 04.
Article en En | MEDLINE | ID: mdl-32531798

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Psoriasis / Antirreumáticos Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Br J Dermatol Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Psoriasis / Antirreumáticos Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Br J Dermatol Año: 2021 Tipo del documento: Article